Cargando…
The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma
Nervous system tumors represent some of the highly aggressive cancers in both children and adults, particularly neuroblastoma and glioblastoma. Many studies focused on the pathogenic role of the Akt pathway and the mechanistic target of Rapamycin (mTOR) complex in mediating the progression of variou...
Autores principales: | Bahmad, Hisham F., Mouhieddine, Tarek H., Chalhoub, Reda M., Assi, Sahar, Araji, Tarek, Chamaa, Farah, Itani, Muhieddine M., Nokkari, Amaly, Kobeissy, Firas, Daoud, Georges, Abou-Kheir, Wassim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173359/ https://www.ncbi.nlm.nih.gov/pubmed/30323898 http://dx.doi.org/10.18632/oncotarget.26088 |
Ejemplares similares
-
Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells
por: Mouhieddine, Tarek H., et al.
Publicado: (2015) -
Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier
por: Bahmad, Hisham F., et al.
Publicado: (2019) -
Stem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects
por: Mouhieddine, Tarek H., et al.
Publicado: (2014) -
Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment
por: Nokkari, Amaly, et al.
Publicado: (2015) -
Correction: Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment
por: Nokkari, Amaly, et al.
Publicado: (2015)